Yarrow Bioscience (YARW) Raw Materials (2021)
Yarrow Bioscience's (YARW) quarterly Raw Materials came in at $3.3 million in Q4 2021.
Yarrow Bioscience (YARW) Raw Materials (2021) Analysis & Trends
Yarrow Bioscience (YARW) has 1 years of Raw Materials data on file, last reported at $3.3 million in Q4 2021.
- Quarterly Raw Materials changed N/A year-over-year to $3.3 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $3.3 million (changed N/A YoY) and the FY2021 annual result came in at $3.3 million, changed N/A from the prior year.
- Raw Materials held at $3.3 million in Q4 2021.
- In the past five years, Raw Materials ranged from a high of $3.3 million in Q4 2021 to a low of $3.3 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Yarrow Bioscience | 32.54 Mn | 9.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 3.30 Mn |